Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis.
about
T cell recognition of weak ligands: roles of signaling, receptor number, and affinityTolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation.Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor: structure optimization and pharmacokineticsAntigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.The characterization of the repertoire of wheat antigens and peptides involved in the humoral immune responses in patients with gluten sensitivity and Crohn's diseaseOral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.Peptide immunotherapy for childhood allergy - addressing translational challenges.The effect of N-methylation of amino acids (Ac-X-OMe) on solubility and conformation: a DFT study.Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy.
P2860
Q24626152-AF5490E8-CA5A-4274-9F88-E6029856964CQ33694715-593EF29C-6C53-4938-A807-8693CF94774AQ33714913-D298181B-DE21-4A13-8868-2BB54F1D4627Q35637379-DC183A97-F1C6-4819-98EA-191BA8B1101FQ35788582-35A2BD08-A622-473B-AB81-DA3EFFF0DFF4Q35835769-F05DC8CC-DCEB-47D7-B929-5CC98FBD08C0Q36095922-CE6597DC-942C-4473-93ED-3A3B8ED09F0BQ36596819-5C0217DC-7AB1-492C-AB98-7CEEA24E0075Q36858402-522A4BA5-6040-414E-B28C-6E6A32BE2612Q36884163-7797D36E-2151-4EE4-AB58-793C5056233DQ37992746-531E9C99-3132-4463-A0D2-43345E7DC21FQ40626372-54E70D5A-3B95-41AB-AAE2-1091D18A902FQ42027896-B54FF717-1023-45AA-8A12-B189DF9105FA
P2860
Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@en
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@nl
type
label
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@en
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@nl
prefLabel
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@en
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@nl
P2093
P2860
P921
P356
P1476
Peptide-based immunotherapy of ...... omyelitis without anaphylaxis.
@en
P2093
Abigail Culshaw
Chen-Yen Chung
Melanie D Leech
Stephen M Anderton
P2860
P304
P356
10.1002/EJI.200737148
P407
P577
2007-12-01T00:00:00Z